+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of nasal continuous positive airway pressure on heart rhythm in patients with obstructive sleep apnea/hypopnea syndrome



Impact of nasal continuous positive airway pressure on heart rhythm in patients with obstructive sleep apnea/hypopnea syndrome



Minerva Medica 105(3): 255-260



A high incidence of nocturnal cardiac rhythm disturbances among patients with obstructive sleep apnea/hypopnea syndrome (OSAHS) has been described in some reports. We wished to examine the prevalence of arrhythmias in OSAHS patients and, in particular, to assess the impact of nasal continuous positive airway pressure (nCPAP) therapy. Three hundred thirty-seven patients with suspected OSAHS; 261 men (77.4%) and 76 women (22.6%); 154 accepted to participate in a second polysomnographic check. Mean age was 53.28±13.6 years. Mean Body Mass Index (BMI) 32.89±6.1 kg/m2. Found statistical significance between patients with normal-mild apnea/hypopnea index (AHI) and moderate to severe AHI (P<0.01). Also, found statistical significance between patients without and with the use of nCPAP (P<0.01). During periods of stable SpO2 there were no apparent oscillations on heart rate. We demonstrated that the impact of nCPAP in patients suffering from OSAHS and heart arrhythmias is positive, helping those patients to have a better quality sleep and probably less cardiovascular risk in a long-term use of the nCPAP apparatus. Males are more prone to OSAHS and to develop tachycardias and bradycardias.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053720424

Download citation: RISBibTeXText

PMID: 24988091


Related references

The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease. Zhonghua Nei Ke Za Zhi 45(3): 188-191, 2006

Adverse effects and adherence to nasal continuous positive airway pressure in patients with obstructive sleep apnea hypopnea syndrome. Nihon Kokyuki Gakkai Zasshi 42(2): 127-131, 2004

Effects of long term nasal continuous positive airway pressure on the blood pressure of patients with obstructive sleep apnea hypopnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 35(9): 687-690, 2014

Validity Of Apnea-Hypopnea Index Determined By Autotitrating Continuous Positive Airway Pressure Device In Patients With Obstructive Sleep Apnea-Hypopnea Syndrome. Chest 132(4): 648-1, 2007

Evaluation of the apnea-hypopnea index determined by the S8 auto-CPAP, a continuous positive airway pressure device, in patients with obstructive sleep apnea-hypopnea syndrome. Journal of Clinical Sleep Medicine 6(2): 146-151, 2010

Homocysteine level in patients with obstructive sleep apnea/hypopnea syndrome and the impact of continuous positive airway pressure treatment. Advances in Clinical and Experimental Medicine 2018, 2018

Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy. Patient Preference and Adherence 11: 769-779, 2017

Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 30(6): 666-669, 2006

Evaluation of short-term use of nocturnal nasal continuous positive airway pressure for a clinical profile and exercise capacity in adult patients with obstructive sleep apnea-hypopnea syndrome. Lung India 32(3): 225-232, 2015

How does serum brain natriuretic peptide level change under nasal continuous positive airway pressure in obstructive sleep apnea-hypopnea syndrome?. Libyan Journal of Medicine 11: 31673, 2017

Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 28(4): 464-471, 2005

Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 26(2): 168-171, 2004

How does serum brain natriuretic peptide level change under nasal continuous positive airway pressure in obstructive sleep apnea-hypopnea syndrome?. Libyan Journal of Medicine 11(1): 31673-31673, 2017

Impact of treatment by nasal continuous positive airway pressure on quality of life of patients with obstructive sleep apnea syndrome. European Respiratory Journal Suppl. 10(25): 311S, Sept, 1997

Short-term and long-term influences of nasal continuous positive airway pressure to sleep architecture of obstructive sleep apnea hypopnea syndrome. Zhonghua Nei Ke Za Zhi 43(9): 651-653, 2004